The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 510.00
Bid: 509.00
Ask: 510.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.196%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 510.00
BAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Final Terms

4 Oct 2016 12:46

RNS Number : 6499L
Babcock International Group PLC
04 October 2016
 

Babcock International Group PLC ("Babcock" or "the Group")

4 October 2016

BABCOCK ANNOUNCES PUBLICATION OF FINAL TERMS

The final terms dated 3 October 2016 (the "Final Terms") relating to the issue by Babcock on 5 October 2016 of GBP 250,000,000 1.875 per cent notes due 2026 (the "Notes") have been submitted to the UK Listing Authority and are available for viewing.

The Notes have been issued pursuant to the base prospectus dated 19 September 2016 (the "Base Prospectus") relating to the £1,800,000,000 Euro Medium Term Note Programme (the "Programme") of Babcock.

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/6499L_-2016-10-4.pdf

A copy of the Final Terms has been submitted to the National Storage Mechanism and will be available at www.morningstar.co.uk/uk/NSM.

For further information, please contact:

Kate Hill - Head of Investor Relations

Babcock International Group PLC

Address: 33 Wigmore Street, London W1U 1QX

 

Telephone: +44 207 355 5314

 

Email: kate.hill@babcockinternational.com

 

DISCLAIMER - INTENDED ADDRESSEES

This announcement is not for distribution in the United States.

Please note that the information contained in the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Final Terms) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms is not addressed. Prior to relying on the information contained in the Final Terms you must ascertain from the Final Terms whether or not you are part of the intended addressees of, and eligible to view, the information contained therein.

In particular, neither this announcement nor the Final Terms shall constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction.

The securities described in the Final Terms have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"). Subject to certain exceptions, the securities may not be offered, sold or delivered within the United States or to, or for the account or benefit of U.S. persons. The securities are being offered and sold outside of the United States in reliance on Regulation S of the Securities Act. There will be no public offering in the United States.

Your right to access this service is conditional upon complying with the above requirements.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFTFZLFBQBFZFBZ
Date   Source Headline
13th Oct 20161:14 pmRNSContract Award
4th Oct 201612:46 pmRNSPublication of Final Terms
23rd Sep 20164:45 pmRNSHolding(s) in Company
20th Sep 201611:37 amRNSPublication of a Prospectus
16th Sep 201612:39 pmRNSHolding(s) in Company
8th Sep 20169:00 amRNSContract Award
16th Aug 20164:44 pmRNSDirector/PDMR Shareholding
29th Jul 20164:30 pmRNSDirector/PDMR Shareholding
21st Jul 20164:32 pmRNSResult of AGM
21st Jul 20167:00 amRNSAnnual General Meeting Trading Update
20th Jul 20163:45 pmRNSHolding(s) in Company
8th Jul 20169:31 amRNSHolding(s) in Company
28th Jun 20169:13 amRNSDirector/PDMR Shareholding
22nd Jun 20169:15 amRNSDirector/PDMR Shareholding
20th Jun 20163:17 pmRNSDirector/PDMR Shareholding
17th Jun 201610:22 amRNSDirector/PDMR Shareholding
16th Jun 20163:44 pmRNSDirector/PDMR Shareholding
16th Jun 20169:14 amRNSAnnual Report and AGM Documents
14th Jun 20163:50 pmRNSDirector/PDMR Shareholding
3rd Jun 20161:56 pmRNSTotal Voting Rights
31st May 20163:29 pmRNSAdditional Listing
25th May 20167:00 amRNSFinal Results
20th May 20168:00 amRNSContract Announcement
18th May 20164:10 pmRNSHolding(s) in Company
12th May 20162:05 pmRNSDirector/PDMR Shareholding
12th May 20162:04 pmRNSDirector/PDMR Shareholding
13th Apr 20164:32 pmRNSDirector/PDMR Shareholding
13th Apr 20164:29 pmRNSDirector/PDMR Shareholding
14th Mar 20162:14 pmRNSDirector/PDMR Shareholding
14th Mar 201610:37 amRNSHolding(s) in Company
29th Feb 201610:02 amRNSHolding(s) in Company
17th Feb 201610:00 amRNSPhoenix II contract award
16th Feb 201610:24 amRNSAdoption of Financial Reporting Standard (FRS) 101
12th Feb 20163:24 pmRNSDirector/PDMR Shareholding
8th Feb 20164:20 pmRNSDirector/PDMR Shareholding
5th Feb 201611:01 amRNSDirector/PDMR Shareholding
3rd Feb 20161:33 pmRNSDirector/PDMR Shareholding
2nd Feb 201611:05 amRNSAscent joint venture contract award
28th Jan 20167:00 amRNSCEO succession
18th Jan 20163:15 pmRNSDirector/PDMR Shareholding
15th Jan 20164:54 pmRNSDirector/PDMR Shareholding
14th Dec 201511:32 amRNSDirector/PDMR Shareholding
11th Dec 201510:02 amRNSS430 (2B) Companies Act 2006
10th Dec 201510:46 amRNSDirectorate Change
1st Dec 20151:38 pmRNSDirector/PDMR Shareholding
26th Nov 201510:14 amRNSHolding(s) in Company
24th Nov 20153:00 pmRNSHolding(s) in Company
24th Nov 20157:00 amRNSHalf Yearly Report
6th Nov 20154:00 pmRNSHolding(s) in Company
23rd Oct 201511:17 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.